Recent Updates
Recently added Catalysts
HIT Positive Sentiment Score: 75/100

Health In Tech Announces Voluntary Extension of Lock-Up Period Stuart, FL.

Key Takeaway: Health In Tech has announced a voluntary extension of the lock-up period for its executive team and Board of Directors by six months. This extension means that shares held by these individuals will remain restricted from sale until June 20, 2026. The decision reflects the leadership's commitment to the company's long-term growth and confidence in its strategies. Following its IPO in December 2024, Health In Tech has been investing in system enhancements and expanding its service offerings within the self-funded healthcare ecosystem.

Market Sentiment Analysis

POSITIVE FACTORS

  • Executive team shows strong commitment by extending lock-up period
  • Demonstrates confidence in the company's long-term growth
  • Continued investment in system enhancements and service offerings
  • Positive outlook for technology and underwriting automation initiatives

Full Press Release Details

Health In Tech Announces Voluntary Extension of Lock-Up Period
Stuart, FL., December 2, 2025 /PRNewswire/ - Health In Tech (Nasdaq:
HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents
across functions, and Board of Directors have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional
six months beyond the original twelve-month lock-up established at the time of the Company's final prospectus issued in connection
with its initial public offering on December 20, 2024.
Under this voluntary extension, all shares held by Health In Tech's
current executive officers and Board of Directors will remain restricted from sale or transfer until June 20, 2026.
"Our leadership team remains highly committed to the long-term
growth of Health In Tech," said Tim Johnson, CEO of Health In Tech. "By choosing to extend their lock-up period, our executives
are demonstrating confidence in the Company's outlook and our ongoing initiatives in technology, underwriting automation, and market
Health In Tech completed its IPO in December 2024, raising gross proceeds
of $9.2 million. The Company has since continued to invest in system enhancements, broaden its distribution network, and expand its service
offerings across the self-funded healthcare ecosystem.
Use of Forward-Looking
Certain statements in this press release are forward-looking statements
for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements
may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business
strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases,
forward-looking statements can be identified by terms such as "may," "will," "should," "design,"
"target," "aim," "hope," "expect," "could," "intend," "plan,"
"anticipate," "estimate," "believe," "continue," "predict," "project,"
"potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements
relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties
and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different
from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You
should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors
which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity,
performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events
and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations,
growth strategy and liquidity.
About Health In Tech
Health In Tech (Nasdaq: "HIT") is an Insurtech platform
company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through
vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales
and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

Frequently Asked Questions

What did Health In Tech announce on December 2, 2025?

Health In Tech announced a voluntary six-month extension of the lock-up period for its shares.

When will the lock-up period end for Health In Tech's executives?

The lock-up period will end on June 20, 2026, for Health In Tech's executives.

How much did Health In Tech raise during its IPO?

Health In Tech raised gross proceeds of $9.2 million during its IPO in December 2024.

What is Health In Tech's business focus?

Health In Tech focuses on improving healthcare processes through automation and vertical integration.

Who is the CEO of Health In Tech?

The CEO of Health In Tech is Tim Johnson.

Last updated: Dec 2, 2025